Pharmaceuticals

Anheuser-Busch offers concessions to S African regulators for SABMiller acquisition

15 Apr 2016

Valeant Pharmaceuticals hires investment banks to review strategic options

15 Apr 2016

Valeant Pharmaceuticals International Inc, one of the most aggressive acquirers in the global pharmaceuticals industry, is considering selling "non-core assets" to help trim its $30-billion debt pile

China to punish 357 officials over illegal vaccines sale

14 Apr 2016

US prescription drugs spending to hit $400 bn in 2020

14 Apr 2016

Theranos may lose licence; top execs face ban

14 Apr 2016

Lonza Group tables bid for US drug delivery technology company Catalent

14 Apr 2016

Global Fund stops sourcing IPCA's anti-malaria drug

08 Apr 2016

Insulin prices more than tripled between 2002 and 2013: study

06 Apr 2016

Pfizer calls halt to $160bn merger with Allergan: report

06 Apr 2016

The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months

US FDA approves Gilead’s third TAF-based HIV therapy, Descovy

06 Apr 2016

New Treasury rules threaten Allergan-Pfizer merger

05 Apr 2016

The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm

NPPA brings down prices of 103 drug formulations

02 Apr 2016

US lawmakers call for lowering price of prostate cancer drug

30 Mar 2016

Government notifies new rules for management of bio-medical waste

28 Mar 2016

US capsule manufacturer Capsugel explores sale or IPO

26 Mar 2016

Relief to pharma cos as Delhi HC stays ban on combination drugs till 28 March

21 Mar 2016

Chinese authorities pledge to crack down on black market sale of vaccines

21 Mar 2016

Government to roll out ‘miracle drug’ treatment for resistant TB

21 Mar 2016

Doctors who got more money from pharma companies prescribed more brand-name drugs: study

19 Mar 2016

Doctors who accept payments from pharmaceutical firms and medical-device makers in the US are twice as likely to prescribe more expensive drugs, reveals a recent study

US FDA approves Bayer’s haemophilia therapy Kovaltry

18 Mar 2016

More drug bans coming: 1,200 FDCs under scanner

18 Mar 2016

Delaware jury rules in favour of Amgen in patent infringement case

17 Mar 2016

US warns drugmaker Emcure for ‘fudging’ test results

17 Mar 2016

Biocon inks co-development and marketing pact with Mexican co for rh-insulin

17 Mar 2016

British respiratory drug maker Vectura to buy Skyepharma for $621 mn

17 Mar 2016